Latest funded news by National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) Funded News
Researchers report that in communities where Medicaid is a more common source of insurance, providers of buprenorphine, an effective treatment for opioid use disorder (OUD), are much less likely to discriminate between Medicaid and privately insured prospective patients, but patients with either type of coverage still face many barriers to obtaining an initial appointment for treatment.
- Health Services Research
- NIH/National Institute on Drug Abuse